Literature DB >> 21402417

Preconditioning effects of tumor necrosis factor-α and glutamate on calcium dynamics in rat organotypic hippocampal cultures.

Orla Watters1, Mark Pickering, John J O'Connor.   

Abstract

During cerebral ischemia, elevation of TNF-α and glutamate to pathophysiological levels in the hippocampus may induce dysregulation of normal synaptic processes, leading ultimately to cell death. Previous studies have shown that patients subjected to a mild transient ischemic attack within a critical time window prior to a more severe ischemic episode may show attenuation in the clinical severity of the stroke and result in a more positive functional outcome. In this study we have investigated the individual contribution of pre-exposure to TNF-α or glutamate in the development of 'ischemic tolerance' to a subsequent insult, using organotypic hippocampal cultures. At 6 days in vitro (DIV), cultures were exposed to an acute concentration of glutamate (30 μM) or TNF-α (5 ng/ml) for 30 min, followed by 24h recovery period. We then examined the effect of the pretreatments on calcium dynamics of the cells within the CA region. We found that pretreatment with TNF-α or glutamate caused in a significant reduction in subsequent glutamate-induced Ca(2+) influx 24h later (control: 100.0 ± 0.8%, n=7769 cells; TNF-α: 76.8 ± 1.0%, n=5543 cells; glutamate: 75.3 ± 1.4%, n=3859 cells; p<0.001). Antagonism of circulating TNF-α (using infliximab, 25 μg/ml), and inhibition of the p38 MAP kinase pathway (using SB 203580, 10 μM) completely reversed this effect. However glutamate preconditioning did not appear to be mediated by p38 MAP kinase signalling, or NMDAR activation as neither SB 203580 nor D-AP5 (100 μM) altered this effect. Glutamate and TNF-α preconditioning resulted in small yet significant alterations in resting Ca(2+) levels (control: 100.0 ± 0.9%, n=2994 cells; TNF-α: 109.7 ± 1.0%, n=2884 cells; glutamate; 93.3 ± 0.8%, n=2899 cells; p<0.001), TNF-α's effect reversed by infliximab and SB 203580. Both TNF-α and glutamate also resulted in the reduction of the proportion (P) of responsive cells within the CA region of the hippocampus (control; P=0.459, 0.451 ≤ x ≥ 0.467, n=14,968 cells, TNF-α; P=0.40, 0.392 ≤ x ≥ 0.407, n=15,218; glutamate; P=0.388, 0.303 ≤ x ≥ 0.396, n=13,919 cells), and in the depression of the frequency of spontaneous Ca(2+) events (vs. control: TNF-α: p>0.00001, D=0.0454; glutamate: p>0.0001, D=0.0534). Our results suggest that attenuation in resting Ca(2+) activity and Ca(2+) related responsiveness of cells within the CA region as a result of glutamate or TNF-α pre-exposure, may contribute to the development of ischemic tolerance.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402417     DOI: 10.1016/j.jneuroim.2011.01.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Gene expression analysis to identify molecular correlates of pre- and post-conditioning derived neuroprotection.

Authors:  Shiv S Prasad; Marsha Russell; Margeryta Nowakowska; Andrew Williams; Carole Yauk
Journal:  J Mol Neurosci       Date:  2012-04-01       Impact factor: 3.444

2.  Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia.

Authors:  Audrey M Wall; Gatambwa Mukandala; Nigel H Greig; John J O'Connor
Journal:  J Neurosci Res       Date:  2015-01-12       Impact factor: 4.164

Review 3.  Targeting tumour necrosis factor-α in hypoxia and synaptic signalling.

Authors:  J J O'Connor
Journal:  Ir J Med Sci       Date:  2013-01-30       Impact factor: 1.568

Review 4.  Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery.

Authors:  Changhong Xing; Eng H Lo
Journal:  Prog Neurobiol       Date:  2016-04-11       Impact factor: 11.685

Review 5.  A role for tumor necrosis factor-α in ischemia and ischemic preconditioning.

Authors:  Orla Watters; John J O'Connor
Journal:  J Neuroinflammation       Date:  2011-08-02       Impact factor: 8.322

6.  Tumor necrosis factor-α promotes the expression of excitatory amino-acid transporter 2 in astrocytes: Optimal concentration and incubation time.

Authors:  Yuemin Ding; Kena Zhang; Shuqin Liu; Qijun Zhang; Chiyuan Ma; Iain C Bruce; Xiong Zhang
Journal:  Exp Ther Med       Date:  2014-10-15       Impact factor: 2.447

7.  Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase.

Authors:  Feng Wang; Jianyong Yin; Zeyuan Lu; Guangyuan Zhang; Junhui Li; Tao Xing; Shougang Zhuang; Niansong Wang
Journal:  EBioMedicine       Date:  2016-05-18       Impact factor: 8.143

8.  Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.

Authors:  Beilei Lei; Hana N Dawson; Briana Roulhac-Wilson; Haichen Wang; Daniel T Laskowitz; Michael L James
Journal:  J Neuroinflammation       Date:  2013-08-20       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.